FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896873878> ?p ?o ?g. }

• W2896873878 abstract "RESUME Introduction. L’objectif de notre etude etait de determiner la prevalence de la proteinurie et ses facteurs associes chez les enfants infectes par le VIH. Methodes. Une etude transversale a ete conduite de janvier a juin 2016 a l’Hopital Laquintinie de Douala (HLD) chez les enfants et adolescents âges de 2 a 19 ans VIH positifs sous traitement antiretroviral (TARV). La proteinurie a ete systematiquement recherchee dans les urines des patients a l’aide de la bandelette reactive Combi screen 11, et une mesure quantitative de la creatinemie a ete faite lorsque la proteinurie etait positive. Les donnees ont ete analysees a l’aide du logiciel Starview version 5.0. et le seuil de significativite etait < 0,05. Resultats. Au total 300 enfants et adolescents VIH positifs ont ete recrutes ; leur âge median etait de 11 (IQ25-75%: 8-15) ans et le sex-ratio de 1,3/1. La prevalence de la proteinurie chez les enfants/adolescents infectes par le VIH sous TARV etait de 5% (15/300) et 86,66% (13/15) des enfants avec proteinurie presentaient une insuffisance renale legere a moderee avec une estimation du debit de filtration glomerulaire (eDFG) (30 a <90 ml/min/1,73 m2). La duree moyenne d’exposition sous TARV des patients etait de 78±41 mois et 53,33% des enfants etaient sous une tritherapie a base de Tenofovir en moyenne depuis 78 + 39 mois. La presence de la leucocyturie etait associee a la presence de la proteinurie de facon significative (OR= 4,33 IC 95% (1,46 – 12,86), p=0,008). Conclusion. La proteinurie est peu frequente, ce qui conforte le role de la nephroprotection induite par le TARV. Nos resultats suggerent l’importance de l’initiation precoce au TARV pour reduire la frequence de la proteinurie et le risque d’atteinte renale. ABSTRACT Introduction. The objective of our study was to determine the prevalence of proteinuria and its associated factors in HIV-infected children. Methods. A cross-sectional study was conducted from January to June 2016 at Douala Laquintinie Hospital (HLD) in HIV-positive children and adolescents aged 2-19 years on antiretroviral therapy (ART). Proteinuria was routinely investigated in the urine of patients using the Combi screen 11 test strip, and a quantitative measure of serum creatinemia was made when proteinuria was positive. The data was analyzed using Starview version 5.0 software. and the threshold of significance was <0.05. Results. A total of 300 HIV positive children and adolescents were recruited, the median age was 11 (IQ25-75%: 8-15 years) and the sex ratio was 1.3/1. The prevalence of proteinuria in HIV-infected children / adolescents on ART was 5% (15/300) and 86.66% (13/15) of children with proteinuria had mild to moderate renal impairment with an estimated glomerular filtration rate (eDFG) (30 to <90 ml/min /1.73 m2). The mean duration of ART exposure for patients was 78 ± 41 months and 53.33% of children were on triple therapy with Tenofovir on average for 78 + 39 months. The presence of leukocyturia was associated with the presence of proteinuria significantly (OR = 4.33 95% CI (1.46-12.86), p = 0.008). Conclusion. Proteinuria was uncommon in our study, reinforcing the role of ART-induced nephroprotection. Our results suggest the importance of early initiation of ART to reduce the frequency of proteinuria and the risk of kidney disease." @default.
• W2896873878 created "2018-10-26" @default.
• W2896873878 creator A5008609764 @default.
• W2896873878 creator A5014941851 @default.
• W2896873878 creator A5034136637 @default.
• W2896873878 creator A5041209038 @default.
• W2896873878 creator A5053402715 @default.
• W2896873878 creator A5065060121 @default.
• W2896873878 creator A5065615481 @default.
• W2896873878 creator A5067953081 @default.
• W2896873878 creator A5079439529 @default.
• W2896873878 creator A5080512027 @default.
• W2896873878 date "2018-10-13" @default.
• W2896873878 modified "2023-09-23" @default.
• W2896873878 title "Prévalence de la Protéinurie et Facteurs Associés chez les Enfants et Adolescents Infectés par le VIH sous Traitement Antirétroviral à l'Hôpital Laquintinie de Douala, Cameroun" @default.
• W2896873878 cites W123133273 @default.
• W2896873878 cites W166029327 @default.
• W2896873878 cites W1970070985 @default.
• W2896873878 cites W1974970176 @default.
• W2896873878 cites W1992163114 @default.
• W2896873878 cites W1998287894 @default.
• W2896873878 cites W2018761667 @default.
• W2896873878 cites W2025366966 @default.
• W2896873878 cites W2030888755 @default.
• W2896873878 cites W2053863977 @default.
• W2896873878 cites W2063362512 @default.
• W2896873878 cites W2076881868 @default.
• W2896873878 cites W2114406400 @default.
• W2896873878 cites W2116902028 @default.
• W2896873878 cites W2118233981 @default.
• W2896873878 cites W2159686293 @default.
• W2896873878 cites W2231145193 @default.
• W2896873878 cites W2322256416 @default.
• W2896873878 hasPublicationYear "2018" @default.
• W2896873878 type Work @default.
• W2896873878 sameAs 2896873878 @default.
• W2896873878 citedByCount "0" @default.
• W2896873878 crossrefType "journal-article" @default.
• W2896873878 hasAuthorship W2896873878A5008609764 @default.
• W2896873878 hasAuthorship W2896873878A5014941851 @default.
• W2896873878 hasAuthorship W2896873878A5034136637 @default.
• W2896873878 hasAuthorship W2896873878A5041209038 @default.
• W2896873878 hasAuthorship W2896873878A5053402715 @default.
• W2896873878 hasAuthorship W2896873878A5065060121 @default.
• W2896873878 hasAuthorship W2896873878A5065615481 @default.
• W2896873878 hasAuthorship W2896873878A5067953081 @default.
• W2896873878 hasAuthorship W2896873878A5079439529 @default.
• W2896873878 hasAuthorship W2896873878A5080512027 @default.
• W2896873878 hasConcept C142462285 @default.
• W2896873878 hasConcept C29456083 @default.
• W2896873878 hasConcept C2993143319 @default.
• W2896873878 hasConcept C3013748606 @default.
• W2896873878 hasConcept C3019165603 @default.
• W2896873878 hasConcept C512399662 @default.
• W2896873878 hasConcept C71924100 @default.
• W2896873878 hasConceptScore W2896873878C142462285 @default.
• W2896873878 hasConceptScore W2896873878C29456083 @default.
• W2896873878 hasConceptScore W2896873878C2993143319 @default.
• W2896873878 hasConceptScore W2896873878C3013748606 @default.
• W2896873878 hasConceptScore W2896873878C3019165603 @default.
• W2896873878 hasConceptScore W2896873878C512399662 @default.
• W2896873878 hasConceptScore W2896873878C71924100 @default.
• W2896873878 hasIssue "4" @default.
• W2896873878 hasOpenAccess W2896873878 @default.
• W2896873878 hasVolume "19" @default.
• W2896873878 isParatext "false" @default.
• W2896873878 isRetracted "false" @default.
• W2896873878 magId "2896873878" @default.
• W2896873878 workType "article" @default.